1. 1172PA first-in-class, first-in-human phase I/IIa trial of CAN04, targeting interleukin-1 receptor accessory protein (IL1RAP), in patients with solid tumors. (23rd October 2018) Authors: Awada, A; Eskens, F A L M; Robbrecht, D G; Lassen, U N; Sorensen, M; Schellens, J H M; de Groot, J S; Jungels, C; Aftimos, P G; Fretland, S O; Thorsson, L; Guren, T K Journal: Annals of oncology Issue: Volume 29(2018)Supplement 8 Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. 813PTreatment of metastatic castration-resistant prostate cancer (mCRPC); Survival by type of progression at initiation of treatment. (23rd October 2018) Authors: Robbrecht, D G; van Soest, R J; Tannock, I F; Oudard, S; Tombal, B; Eisenberger, M; Mercier, F; de Wit, R Journal: Annals of oncology Issue: Volume 29(2018)Supplement 8 Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗